A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.

Gabriele Siegler; Thomas Bertsch; K Link; MC Miller; S Holdenrieder; L Mueller; V Kunzmann; YD Ko; OJ Stoetzer; I Suttmann; J Braess; U Jaehde; M Roessler; B Moritz; SJ Salamone; Martin Wilhelm

A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.

Gabriele Siegler, Thomas Bertsch, K Link, MC Miller, S Holdenrieder, L Mueller, V Kunzmann, YD Ko, OJ Stoetzer, I Suttmann, J Braess, U Jaehde, M Roessler, B Moritz, SJ Salamone, Martin Wilhelm

Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine - Central Laboratory
Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to conference › Abstract

Original language	English
Publication status	Published - 2015
Event	Paracelsus Science Get Together - Nürnberg, Germany Duration: 3 Jul 2015 → …

Conference with scientific content

Conference with scientific content	Paracelsus Science Get Together
Country/Territory	Germany
City	Nürnberg
Period	3/07/15 → …

1 Poster

A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.
Siegler, G., Bertsch, T., Link, K., Miller, M., Holdenrieder, S., Mueller, L., Kunzmann, V., Ko, Y., Stoetzer, O., Suttmann, I., Braess, J., Jaehde, U., Roessler, M., Moritz, B., Salamone, S. & Wilhelm, M., 2015.
Research output: Contribution to conference › Poster

Cite this

Siegler, G., Bertsch, T., Link, K., Miller, MC., Holdenrieder, S., Mueller, L., Kunzmann, V., Ko, YD., Stoetzer, OJ., Suttmann, I., Braess, J., Jaehde, U., Roessler, M., Moritz, B., Salamone, SJ., & Wilhelm, M. (2015). A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.. Abstract from Paracelsus Science Get Together, Nürnberg, Germany.

@conference{a238212f68cb4d8cbac3444d8e6c3249,

title = "A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.",

author = "Gabriele Siegler and Thomas Bertsch and K Link and MC Miller and S Holdenrieder and L Mueller and V Kunzmann and YD Ko and OJ Stoetzer and I Suttmann and J Braess and U Jaehde and M Roessler and B Moritz and SJ Salamone and Martin Wilhelm",

year = "2015",

language = "English",

note = "Paracelsus Science Get Together ; Conference date: 03-07-2015",

}

Siegler, G , Bertsch, T, Link, K, Miller, MC, Holdenrieder, S, Mueller, L, Kunzmann, V, Ko, YD, Stoetzer, OJ, Suttmann, I, Braess, J, Jaehde, U, Roessler, M, Moritz, B, Salamone, SJ & Wilhelm, M 2015, 'A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.', Paracelsus Science Get Together, Nürnberg, Germany, 3/07/15.

A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens. / Siegler, Gabriele ; Bertsch, Thomas; Link, K et al.
2015. Abstract from Paracelsus Science Get Together, Nürnberg, Germany.

Research output: Contribution to conference › Abstract

TY - CONF

T1 - A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.

AU - Siegler, Gabriele

AU - Bertsch, Thomas

AU - Link, K

AU - Miller, MC

AU - Holdenrieder, S

AU - Mueller, L

AU - Kunzmann, V

AU - Ko, YD

AU - Stoetzer, OJ

AU - Suttmann, I

AU - Braess, J

AU - Jaehde, U

AU - Roessler, M

AU - Moritz, B

AU - Salamone, SJ

AU - Wilhelm, Martin

PY - 2015

Y1 - 2015

M3 - Abstract

T2 - Paracelsus Science Get Together

Y2 - 3 July 2015

ER -

Siegler G , Bertsch T, Link K, Miller MC, Holdenrieder S, Mueller L et al.. A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.. 2015. Abstract from Paracelsus Science Get Together, Nürnberg, Germany.